In mice, genetic disruption of Sh2b1 also results in obesity, insulin resistance, type-2 diabetes, severe leptin resistance, and metabolic dysfunction-associated steatotic liver disease. This evidence concerns the gene SH2B1 and obesity due to melanocortin 4 receptor deficiency.